Clinton Says Pfizer-Allergan Leaves Taxpayers 'Holding the Bag'
- Democratic front-runner promises plan to curb inversions
- $160 billion deal moves Pfizer's tax headquarters to Ireland
Is Hillary Clinton's Strategy Paying Off?
This article is for subscribers only.
Democratic presidential front-runner Hillary Clinton attacked Pfizer Inc.’s plan to move its tax address to Ireland through a merger with Allergan Plc, saying it would hurt U.S. taxpayers and urging a crackdown on such deals.
“This proposed merger, and so-called inversions by other companies, will leave U.S. taxpayers holding the bag,” she said in a statement released Monday by her campaign. “As president, I will fight to reform our tax system to reward growth, innovation, and job creation here in the United States. We cannot delay in cracking down on inversions that erode our tax base.”